Search
for
Sort by
Research 31–60 of 1000+
- 466 Clinical technique and outcomes of platelet-rich plasma application for treatment of androgenic and scarring alopecia, acne scarring, melasma, and facial rejuvenation: A prospective multicenter study
- Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain
- Developmental and reproductive outcome of F1 generation of Wistar rats exposed to Acanthus montanus aqueous extract during organogenesis
- Nanoparticles enhance therapeutic outcome in inflamed skin therapy
- Standardization of SMP procedure and its impact on outcome
- Real-World Systemic Treatment Patterns and Outcomes of Children With Severe Alopecia Areata: A French Nationwide Study (ESTAPED Cohort)
- Effect of Platelet-Rich Plasma on Clinical Outcomes of Androgenic Alopecia
- Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
- Skin Impacts and Tradeoffs of GLP-1 Therapy: Improved Patient-Reported Outcomes of Inflammatory Skin Disease in the Era of “Ozempic Face”
- Combining 675 nm Laser with Isotretinoin for Enhanced Acne Vulgaris Treatment Outcomes
- Plan of analysis for the study "Maternal Hair Cortisol Concentration Trajectories throughout Pregnancy and Adverse Childhood Experiences"
- The impact of 1-hour plasma glucose on the metabolic characteristics and pregnancy outcomes in polycystic ovary syndrome
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
- Minoxidil for patchy alopecia areata: systematic review and meta‐analysis
- Exosome-Based Therapies for Alopecia: A Systematic Review of Clinical Efficacy and Safety
- Safety concerns of paternal drug exposure on fertility, pregnancy and offspring: An analysis based on the FDA adverse event reporting system
- Drug-induced hair colour changes
- A Gender Hypothesis of sex disparities in adverse drug events
- Effectiveness and safety of oral Janus kinase inhibitors in patients aged ≤12 with alopecia areata: a systematic review and meta-analysis
- Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Patterns of Coverage
- Atopic dermatitis and the outcomes of pregnancy and offspring: A nationwide population‐based study in Taiwan
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Pregnancy Outcomes with Paternal Exposure to Finasteride, a Synthetic 5-Alpha-Reductase Inhibitor: A Case Series
- Managing adverse events associated with vismodegib in the treatment of basal cell carcinoma
- Cutaneous toxicities of new treatments for melanoma
- Nilotinib-Induced Keratosis Pilaris
- Prospective Outcomes After Serial Platelet‐Rich Plasma (PRP) Injection in Vocal Fold Scar and Sulcus
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons